Alembic Pharmaceuticals Ltd. | Cash Flow
Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
3,106
3,591
9,362
5,291
5,413
Depreciation, Depletion & Amortization
405
444
722
830
1,055
Funds from Operations
2,981
3,314
8,058
4,903
4,686
Changes in Working Capital
721
1,625
1,389
1,656
1,809
Net Operating Cash Flow
2,260
1,689
9,447
3,246
2,878
Capital Expenditures
820
2,236
3,011
5,101
8,218
Sale of Fixed Assets & Businesses
1
1
1
194
144
Purchase/Sale of Investments
-
342
81
36
-
Net Investing Cash Flow
819
2,577
3,091
4,871
8,858
Cash Dividends Paid - Total
546
655
787
901
908
Issuance/Reduction of Debt, Net
854
1,571
1,325
386
6,191
Net Financing Cash Flow
1,401
917
2,110
1,287
5,283
Net Change in Cash
41
29
4,247
2,912
697
Free Cash Flow
1,441
547
6,436
1,855
4,616
Net Assets from Acquisitions
-
-
-
-
784
About Alembic Pharmaceuticals
View Profile
